Clinical Trial Update: The Effect of Algae Dunaliella Bardawil on Psoriasis (2) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Dunaliella bardawil algae extract for psoriasis was withdrawn, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Dunaliella bardawil algae extract (Dunaliella bardawil algae extract)

Snippet

Sponsor: Sheba Medical Center | Conditions: Psoriasis | Phase 3 | Status: WITHDRAWN